Anti-FZD Antibody (Vantictumab)
Catalog No.
F2026
Anti-FZD Antibody (Vantictumab)
Featured Products
Vantictumab (OMP-18R5) is a fully human IgG2 monoclonal antibody. Vantictumab inhibits Wnt pathway signaling by binding to FZD1/2/5/7/8 receptors. Vantictumab can be used in anti-cancer research, such as metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
143.16 kDa
Dry ice
1345009-45-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
OMP-18R5
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Human
Unconjugated
Monoclonal
Protein A
IgG2SA
ELISA, FACS, Kinetics, Functional assay, Animal Model
FZD
Please avoid freeze-thaw cycles.